The study — which didn't incorporate tirzepatide as part of the Examination — was framed as a counterpoint to another study that uncovered that GLP-1 agonists increased the chance for pancreatitis.The current class of anti-obesity medication is proving remarkably powerful at eliminating excessive lbs. Nevertheless, a phase three randomized medi